官方服务：
资源简介：
OVCAR-3 Cells: Control vs. FBA-TPQ treated
应用场景：
创建时间：
2011-11-12
相关数据集
Ovarian Cancer Drugs Market Executive Summary: Key Insights and Statistics (2024-2033)
Access the summary of the Ovarian Cancer Drugs market report, featuring key insights, executive summary, market size, CAGR, growth rate, and future outlook.
www.emergenresearch.com2023-11-22 更新160
Ovarian Cancer Drugs Market Size: Comprehensive Overview and Forecast (2024-2033)
Get detailed insights into the current valuation of Ovarian Cancer Drugs market size, including growth analysis, current market status and future market projections.
www.emergenresearch.com2023-11-22 更新80
Epithelial Ovarian Cancer Drugs Market
Report of Epithelial Ovarian Cancer Drugs Market is covering the summarized study of several factors encouraging the growth of the market such as market size, market type, major regions and end user a
IMR REPORTS50
Ovarian Cancer Drugs Market News: Mergers & Acquisitions and Key Industry Developments (2024-2033)
Stay updated with the latest Ovarian Cancer Drugs Market News. Get insights on recent mergers, acquisitions, and key industry developments.
www.emergenresearch.com2023-11-22 更新140
Exploiting the Synergy between Carboplatin and ABT-737 in the Treatment of Ovarian Carcinomas
Platinum drug-resistance in ovarian cancers mediated by anti-apoptotic proteins such as Bcl-xL is a major factor contributing to the chemotherapeutic resistance of recurrent disease. Consequently, con
NIAID Data Ecosystem50
